Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitReceivables - NetReceivables - OtherShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

Medicure (MCUJF) Gross Profit (2016 - 2025)

Medicure has reported Gross Profit over the past 17 years, most recently at $1.9 million for Q4 2025.

  • For Q4 2025, Gross Profit fell 21.49% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $8.4 million, down 12.09%, while the annual FY2025 figure was $8.4 million, 10.09% down from the prior year.
  • Gross Profit for Q4 2025 was $1.9 million at Medicure, down from $2.0 million in the prior quarter.
  • Over five years, Gross Profit peaked at $3.2 million in Q4 2022 and troughed at $1.9 million in Q4 2025.
  • A 5-year average of $2.6 million and a median of $2.6 million in 2023 define the central range for Gross Profit.
  • Biggest five-year swings in Gross Profit: soared 1317.24% in 2021 and later plummeted 31.49% in 2025.
  • Year by year, Gross Profit stood at $3.0 million in 2021, then rose by 7.03% to $3.2 million in 2022, then fell by 0.29% to $3.2 million in 2023, then dropped by 23.07% to $2.5 million in 2024, then fell by 21.49% to $1.9 million in 2025.
  • Business Quant data shows Gross Profit for MCUJF at $1.9 million in Q4 2025, $2.0 million in Q3 2025, and $2.5 million in Q2 2025.